| Product Code: ETC4720380 | Publication Date: Nov 2023 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The Netherlands continues to rely on imports of human insulin, with Belgium, Hungary, USA, Japan, and Sweden being the top exporting countries in 2024. Despite high concentration with a high Herfindahl-Hirschman Index (HHI), the compound annual growth rate (CAGR) from 2020 to 2024 stands at a steady 3.85%. However, there was a significant decline in growth rate from 2023 to 2024, with a decrease of -42.93%. This fluctuation suggests potential shifts in market dynamics and emphasizes the need for continuous monitoring and analysis in the human insulin import sector in the Netherlands.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Human Insulin Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Human Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Human Insulin Market - Industry Life Cycle |
3.4 Netherlands Human Insulin Market - Porter's Five Forces |
3.5 Netherlands Human Insulin Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Netherlands Human Insulin Market Revenues & Volume Share, By Diabetes Type, 2021 & 2031F |
3.7 Netherlands Human Insulin Market Revenues & Volume Share, By Delivery Devices, 2021 & 2031F |
3.8 Netherlands Human Insulin Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 Netherlands Human Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in the Netherlands |
4.2.2 Growing aging population leading to higher demand for insulin |
4.2.3 Technological advancements in insulin delivery systems |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for insulin products |
4.3.2 High cost associated with insulin treatment |
4.3.3 Competition from alternative diabetes treatment options |
5 Netherlands Human Insulin Market Trends |
6 Netherlands Human Insulin Market Segmentations |
6.1 Netherlands Human Insulin Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Human Insulin Market Revenues & Volume, By Analogue Insulin, 2021-2031F |
6.1.3 Netherlands Human Insulin Market Revenues & Volume, By Traditional Human Insulin, 2021-2031F |
6.2 Netherlands Human Insulin Market, By Diabetes Type |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Human Insulin Market Revenues & Volume, By Type 1 Diabetes, 2021-2031F |
6.2.3 Netherlands Human Insulin Market Revenues & Volume, By Type 2 Diabetes, 2021-2031F |
6.2.4 Netherlands Human Insulin Market Revenues & Volume, By Gestational Diabetes, 2021-2031F |
6.2.5 Netherlands Human Insulin Market Revenues & Volume, By Prediabetes, 2021-2031F |
6.3 Netherlands Human Insulin Market, By Delivery Devices |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Human Insulin Market Revenues & Volume, By Syringes, 2021-2031F |
6.3.3 Netherlands Human Insulin Market Revenues & Volume, By Pens, 2021-2031F |
6.3.4 Netherlands Human Insulin Market Revenues & Volume, By Pumps, 2021-2031F |
6.3.5 Netherlands Human Insulin Market Revenues & Volume, By Others, 2021-2031F |
6.4 Netherlands Human Insulin Market, By End-users |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Human Insulin Market Revenues & Volume, By Home Healthcare, 2021-2031F |
6.4.3 Netherlands Human Insulin Market Revenues & Volume, By Hospitals, 2021-2031F |
6.4.4 Netherlands Human Insulin Market Revenues & Volume, By Over The Counter (OTC), 2021-2031F |
6.4.5 Netherlands Human Insulin Market Revenues & Volume, By Clinics, 2021-2031F |
6.4.6 Netherlands Human Insulin Market Revenues & Volume, By Others, 2021-2031F |
7 Netherlands Human Insulin Market Import-Export Trade Statistics |
7.1 Netherlands Human Insulin Market Export to Major Countries |
7.2 Netherlands Human Insulin Market Imports from Major Countries |
8 Netherlands Human Insulin Market Key Performance Indicators |
8.1 Average time taken for insulin product approval by regulatory authorities |
8.2 Adoption rate of new insulin delivery technologies |
8.3 Percentage of diabetic population in the Netherlands using insulin therapy |
9 Netherlands Human Insulin Market - Opportunity Assessment |
9.1 Netherlands Human Insulin Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Netherlands Human Insulin Market Opportunity Assessment, By Diabetes Type, 2021 & 2031F |
9.3 Netherlands Human Insulin Market Opportunity Assessment, By Delivery Devices, 2021 & 2031F |
9.4 Netherlands Human Insulin Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 Netherlands Human Insulin Market - Competitive Landscape |
10.1 Netherlands Human Insulin Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Human Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |